Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 4
2009 1
2010 1
2014 1
2015 3
2017 1
2018 3
2020 3
2021 5
2022 10
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL).
Yoshida S, Takahara T, Arita Y, Ito M, Hayakawa S, Oguchi T, Komai Y, Numao N, Yuasa T, Inoue M, Ushijima H, Kudo S, Shimano Y, Nakamura Y, Uchida Y, Uehara S, Tanaka H, Yaegashi H, Izumi K, Yokoyama M, Matsuoka Y, Yoshioka Y, Konishi K, Nakanishi K, Nagahara A, Hirakawa A, Koike R, Koga F, Nishimura K, Mizokami A, Yonese J, Kageyama Y, Yoshimura R, Fujii Y. Yoshida S, et al. Among authors: inoue m. BMC Urol. 2023 Mar 6;23(1):33. doi: 10.1186/s12894-023-01202-z. BMC Urol. 2023. PMID: 36879257 Free PMC article. Clinical Trial.
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort.
Tohi Y, Ishikawa R, Kato T, Miyakawa J, Matsumoto R, Mori K, Mitsuzuka K, Inokuchi J, Matsumura M, Shiga K, Naito H, Kohjimoto Y, Kawamura N, Inoue M, Akamatsu S, Terada N, Miyazawa Y, Narita S, Haba R, Sugimoto M. Tohi Y, et al. Among authors: inoue m. Jpn J Clin Oncol. 2023 Oct 4;53(10):984-990. doi: 10.1093/jjco/hyad088. Jpn J Clin Oncol. 2023. PMID: 37496400
Undifferentiated prostate cancer treated with docetaxel.
Kobayashi M, Yokoyama M, Inoue M, Fujii Y. Kobayashi M, et al. Among authors: inoue m. IJU Case Rep. 2020 Apr 20;3(4):125-127. doi: 10.1002/iju5.12162. eCollection 2020 Jul. IJU Case Rep. 2020. PMID: 33392469 Free PMC article.
Paraganglioma with High Levels of Dopamine, Dopa Decarboxylase Suppression, Dopamine β-hydroxylase Upregulation and Intra-tumoral Melanin Accumulation: A Case Report with a Literature Review.
Nezu M, Hirotsu Y, Amemiya K, Tateno T, Takizawa S, Inoue M, Mochizuki H, Hosaka K, Chik C, Oyama T, Omata M. Nezu M, et al. Among authors: inoue m. Intern Med. 2023 Jul 1;62(13):1895-1905. doi: 10.2169/internalmedicine.0743-22. Epub 2022 Nov 16. Intern Med. 2023. PMID: 36384901 Free PMC article. Review.
Dedifferentiated solitary fibrous tumor of the kidney: A case report.
Izumi K, Inoue M, Maruyama R, Ishikawa A, Kanda H, Kageyama Y. Izumi K, et al. Among authors: inoue m. Urol Case Rep. 2022 May 1;43:102100. doi: 10.1016/j.eucr.2022.102100. eCollection 2022 Jul. Urol Case Rep. 2022. PMID: 35573086 Free PMC article.
A case of juvenile-onset pheochromocytoma with KIF1B p.V1529M germline mutation.
Nezu M, Hirotsu Y, Amemiya K, Katsumata M, Watanabe T, Takizawa S, Inoue M, Mochizuki H, Hosaka K, Oyama T, Omata M. Nezu M, et al. Among authors: inoue m. Endocr J. 2022 Jun 28;69(6):705-716. doi: 10.1507/endocrj.EJ21-0475. Epub 2022 Jan 19. Endocr J. 2022. PMID: 35046208 Free article.
Pretreatment Hemoglobin Levels and Platelet-to-Lymphocyte Ratio Predict Survival Benefit from Pembrolizumab in Advanced Urothelial Carcinoma.
Kurashina R, Ando K, Inoue M, Maruyama R, Mitani K, Takenobu H, Haruta M, Onuki R, Matsuoka Y, Kamijo T, Kageyama Y. Kurashina R, et al. Among authors: inoue m. Cancer Diagn Progn. 2023 Mar 3;3(2):230-235. doi: 10.21873/cdp.10206. eCollection 2023 Mar-Apr. Cancer Diagn Progn. 2023. PMID: 36875313 Free PMC article.
44 results